Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.00USD
19 Jul 2019
Change (% chg)

$-0.01 (-0.14%)
Prev Close
$7.01
Open
$6.95
Day's High
$7.05
Day's Low
$6.91
Volume
23,547
Avg. Vol
54,809
52-wk High
$11.16
52-wk Low
$5.99

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.592
FY 2018 Dec '18 0.00 -0.621
Sep '18 0.00 -0.542
Jun '18 2.38 -0.457
Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 5 0.32 1.60 0.00 0.80
Quarter Ending Dec-19 5 0.36 1.80 0.00 0.90
Year Ending Dec-19 6 1.07 6.40 0.00 3.15
Year Ending Dec-20 6 13.27 79.60 0.00 8.79
Earnings (per share)
Quarter Ending Sep-19 6 -0.49 -0.40 -0.66 -0.63
Quarter Ending Dec-19 6 -0.50 -0.42 -0.70 -0.64
Year Ending Dec-19 6 -2.07 -1.81 -2.58 -2.28
Year Ending Dec-20 6 -1.91 -1.26 -2.24 -2.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.41 32.67
P/E High - Last 5 Yrs. -- 147.75 47.29
P/E Low - Last 5 Yrs. -- 48.01 23.88
Beta -- 1.09 0.89
Price to Sales (TTM) 18.07 49.46 7.92
Price to Book (MRQ) 1.40 10.14 5.39
Price to Tangible Book (MRQ) 1.40 13.75 6.71
Price to Cash Flow (TTM) -- 55.97 24.37
% Owned Institutions 64.29 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.00 40.25

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.72 205.69 12.24
Sales (TTM) vs TTM 1 Yr. Ago -0.67 49.06 7.74
Sales - 5 Yr. Growth Rate -- 22.81 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -1.90 75.26 43.01
EPS (TTM) vs TTM 1 Yr. Ago -20.52 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 14.98 3.59 3.03
LT Debt to Equity (MRQ) 0.00 18.58 10.21
Total Debt to Equity (MRQ) 0.00 31.20 14.56
Interest Coverage (TTM) -- -43.39 29.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.07 52.21
Gross Margin - 5 Yr. Avg. -- 60.31 50.40
EBITD Margin (TTM) -508.77 -- --
EBITD - 5 Yr. Avg -- -110.44 13.16
Operating Margin (TTM) -512.56 -184.27 6.88
Operating Margin - 5 Yr. Avg. -- -126.89 8.97
Pre-Tax Margin (TTM) -506.49 -175.02 6.08
Pre-Tax Margin - 5 Yr. Avg. -- -132.65 9.26
Net Profit Margin (TTM) -506.49 -181.72 2.72
Net Profit Margin - 5 Yr. Avg. -- -137.02 5.63
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) 161,900 7,672,423 887,716,663
Net Income/Employee (TTM) -820,000 533,977 101,894,138
Receivable Turnover (TTM) 3.42 6.28 5.94
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.07 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.06 6.42 11.18
Return on Assets - 5 Yr. Avg. -- 5.51 12.34
Return on Investment (TTM) -36.00 8.94 14.49
Return on Investment - 5 Yr. Avg. -- 6.84 16.03
Return on Equity (TTM) -36.04 10.07 15.79
Return on Equity - 5 Yr. Avg. -- 8.42 17.02
  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.07 19.79 84 99
13 Week 57.37 49.71 91 95
26 Week -26.41 -32.01 26 97
52 Week -23.68 -35.31 35 70
YTD 22.64 7.71 62 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.77%
# of Holders: 109
Total Shares Held: 22,724,740
3 Mo. Net Change: 45,445
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 8
# Reduced Positions: 5
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.